A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 573-579

  Donskey, Curtis J ^b   Schreiber, John R ^b   Jacobs, Michael R ^b   Shekar, Rajah ^b   Salata, Robert A ^b   Gordon, Steve ^b   Whalen, Christopher C ^b   Smith, Forrest ^b   Rice, Louis B ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; METICILLIN; PIPERACILLIN; STREPTOMYCIN; SULBACTAM; TAZOBACTAM; TEICOPLANIN; TETRACYCLINE; TICARCILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPIDEMIC; GENOTYPE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TEACHING HOSPITAL; UNITED STATES;

EID: 0032871020     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598636     Document Type: Article

References (33)

1. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
2. Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634-7.
3. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
4. Livornese LLJ, Dias S, Samel C. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
5. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-7.
6. Perlada DE, Smulian AG, Cushion MT. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol 1997;35:2342-7.
7. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993;31:1609-11.
8. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
9. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.
10. Mato R, de Lancastre H, Roberts RB, Tomasz A. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital. Microb Drug Resist 1996;2:309-17.
11. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mentality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and or surgical patients. Clin Infect Dis 1995;21: 45-50.
12. Anglim AM, Klym B, Byers KE, Scheld M, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomytin-resistant Enterococcus faecium. Arch Intern Med 1997; 157:1132-6.
13. Pallares R, Pujol M, Peña C, Ariza J, Martin R, Gudiol F. Cephalosporins as a risk factor for nosocomial Enterococcus faecalis bacteremia. Arch Intern Med 1993;153:1581-6.
14. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of β-lactamase-negative, ampicillin-resistant enterococcus. Arch Intern Med 1992;152:1457-61.
15. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
16. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998;26:1127-33.
17. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
18. Beezhold DW, Slaughter S, Hayden MK, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1997;24:704-6.
19. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. NCCLS document M7-A3. Wayne, PA: National Committee for Clinical Laboratory Standards, 1993.
20. Storrs MJ, Poyart-Salmeron C, Trieu-Cuot P, Courvalin P. Conjugative transposition of Tn916 requires the excisive and integrative activities of the transposon encoded integrase. J Bacteriol 1991;173:4347-52.
21. Miele A, Bandera M, Goldstein BP. Use of primers selective for vancomvcin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother 1995;39:1772-8.
22. Patel R, Uhl JR, Kohner P, et al. DNA sequence variation within vanA, vanB, and vanC-2 genes of clinical Enterococcus spp. isolates - implications for laboratory testing methods. Antimicrob Agents Chemother 1998;42:202-5.
23. Carias LL, Rudin SD, Donskey CJ, Rice LB. Genetic linkage and cotransfer of a novel, vanB-encoding transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998;180:4426-34.
24. Bonten MJM, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998;158:1127-32.
25. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996,23: 760-6.
26. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecum infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-72.
27. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996;40:1526-30.
28. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclerq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996;173:1129-36.
29. Taylor EW, Poxon V, Alexander-Williams J, Jackson D. Biliary excretion of piperacillin. J Int Med Res 1983;11:28-31.
30. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990;34: 2193-9.
31. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
32. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
33. Peña C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998;42:53-8.